Healthcare -
Biotechnology - NASDAQ - US
$ 0.757
-0.264 %
$ 41.7 M
Market Cap
-0.43
P/E
PRLD - COMMON STOCK REPURCHASED
Common Stock Repurchased PRLD - Prelude Therapeutics Incorporated
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR